Asymptomatic serologic reactivation in patients with lupus nephritis in clinical remission: to treat or not to treat?
Kidney International · 2026-07 · 110 (1) · 39-41
DOI: 10.1016/j.kint.2026.04.005 ↗Kurz gefasst
Kommentar in der Zeitschrift Kidney International, 2026-07. Verfasst von Antonis Fanouriakis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology and Clinical Immunology Unit, "Attikon" University Hospital, Medical School National and Kapodistrian University of Athens, Athens, Gree…. Hauptthemen laut MEDLINE: Lupus Nephritis, Immunosuppressive Agents, Antibodies, Antinuclear, Watchful Waiting. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Lupus nephritis flares are occasionally preceded by a rise in serologic activity. To date, watchful waiting is the suggested approach for patients with such a serologic reactivation. Yap et al. performed a randomized trial testing a pre-emptive increase in immunosuppression versus watchful monitoring in patients with stable lupus nephritis who had a rise in their anti-double-stranded DNA antibodies. We discuss their results in the context of the current landscape and expanding therapeutic options for the management of lupus nephritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Rheumatology and Clinical Immunology Unit, "Attikon" University Hospital, Medical School National and Kapodistrian University of Athens, Athens, Greece. Electronic address: afanour@med.uoa.gr.
- Center of Expertise for Lupus, Vasculitis and Complement-Mediated Systemic Diseases, Department of Internal Medicine-Section Nephrology, Leiden University Medical Center, Leiden, the Netherlands.
Zitieren
APA
Fanouriakis, A., & Teng, Y. K. O. (2026). Asymptomatic serologic reactivation in patients with lupus nephritis in clinical remission: to treat or not to treat?. Kidney International, 110(1), 39-41. https://doi.org/10.1016/j.kint.2026.04.005
Vancouver
Fanouriakis A, Teng YKO. Asymptomatic serologic reactivation in patients with lupus nephritis in clinical remission: to treat or not to treat?. Kidney International. 2026;110(1):39-41. doi:10.1016/j.kint.2026.04.005
BibTeX
@article{Fanouriakis2026,
author = {Fanouriakis, Antonis and Teng, Y K Onno},
title = {Asymptomatic serologic reactivation in patients with lupus nephritis in clinical remission: to treat or not to treat?},
journal = {Kidney International},
year = {2026},
volume = {110},
number = {1},
pages = {39--41},
doi = {10.1016/j.kint.2026.04.005}
}
EUVIMED